arrow
A

Angharad Pryce

university hospital southampton
H指数:4
被引数:44

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bridging practices prior to brexucabtagene autoleucel for mantle cell lymphoma in the United Kingdom: An analysis of modality, response, toxicity and survival

英国 mantle cell lymphoma 患者接受 brexucabtagene autoleucel 治疗前的过渡治疗实践:对治疗模式、疗效、毒性和生存的分析

2026-03-080
OA
Outcomes of second-line axicabtagene ciloleucel for large B-cell lymphoma in the UK

英国大型B细胞淋巴瘤患者接受二线阿西替尼西洛鲁塞注射液治疗的结局

2026-02-190
OAAI
Genetic findings of potential donor origin in cells used for cell and gene therapy: Recommendations from the World Marrow Donor Association (WMDA)

细胞与基因治疗所用细胞中潜在供者来源的遗传学发现:世界骨髓捐赠者协会(WMDA)的建议

2025-11-260
OAAI
Hematopoietic Stem Cell (HSC) Graft Cryopreservation Effects on Outcomes of Patients with Hematologic Malignancies: the Multicenter United Kingdom Experience During the COVID-19 Pandemic

造血干细胞(HSC)移植物冷冻保存对血液恶性肿瘤患者预后的影响:COVID-19疫情期间英国多中心经验

2025-04-080
PRE
Genetic Findings of Potential Donor Origin following Hematopoietic Cell Transplantation: Recommendations on Donor Disclosure and Genetic Testing from the World Marrow Donor Association
2024-02-013
OAAI